CO-EDITORIALeQuality of Life: The FinalCommonPathway T he decision to publish a thematic issue of the Journal of Palliative Care devoted to quality of life assessment is both timely and necessary. Quality of life as a concept has become very much the vogue, perhaps because the term is so "userfriendly." The methodologies derived from the concept offer the potential of a final common pathway criterion for assessing the multidisciplinary input of basic scientists and clinicians to the diagnostic and treatment process. As such, it could become the dominant criterion upon which decisions are made. That being the case, the properties, strengths, and weaknesses of the quality of life model must be clearly understood. Otherwise, this unfettered popularity carries the risk of discrediting a significant and evolving health care evaluation science. When evaluating any methodology, important criteria include the presence of a suitable conceptual framework, rigorously developed and tested measurement methods with well-defined properties and limitations, and a broad sense of the implications of the methodology and the possible results of its application.
The Journal contributors who address these isSues are drawn from around the world and from different disciplines, attesting to the wide interest in quality of life assessment. Included among the authors are clinicians, health policy analysts, and health policymakers, all approaching the issue from their particular perspective. This is important, because even though quality of life in the technical sense has become a patient-centred selfassessment technique, influences on quality of life are multifactorial, and the implications of research in the field are already beginning to shape the treatment of individual patients, the clinical trial process, and the formulation of health care policy.
The papers address three broad areas: concept, assessment, and evaluation and interpretation. As short papers they are intended as overviews.
eaders considering a fuller involvement in the field are encouraged to read from the rapidly accumulating literature (1, 2, 3, 4, 5, 6 ).
Ourhopeisthat thisthematic overview will provide the basis for criticalevaluation of contributions to the field and perhaps encourage some to share in the investigativejourney. At the very least, accepting the concept as representing critical evaluation with a human face reinforces the patient as a person.
The timing of this issue is also propitious for palliative care. Through the efforts of the World Health Organization and a cohort of pioneering nurses and clinicians, palliative care is now a part of mainstream medicine. More significant, palliation is no longer an approach reserved for those patients facing imminent death, but instead represents a multidisciplinary approach to the alleviation of suffering at any point in the illness trajectory. The evaluative rigor of the quality of life approach may serve to strengthen an already deeply caring discipline.Thus,forboththepalliativecareexpertandthe quality of life researcher, this Journal issue presents an opportunity. What follows is some context.
Medicine is highly culture-dependent. Models of disease and methods of treatment are inextricably rooted in their host culture (7) . What is illness or disease (obesity) in one setting may beviewed as an inconsequential norm (pudgy good health) elsewhere.
What is consistent, however, is the seminal social importance of health care and the physician. Ifhealth is the basis of life, and the health care provider the instrument of wellness, then to the extent that the community considers wellness and lifespan to be predominantsocial issues, every aspect of illness and medicine ultimately becomes an abiding interest of the state. Where the state is a tribal society, the traditional healer is the health shaman. When the state isa govemmentinthe contemporarygeopolitical sense, the provision of health becomes both a responsibility and a political instrument (8) . Dr. Charles Olweny has a vast experience in the developing world, especially Africa. In bringing this experience to bear, his paper makes the case for a global construct for quality of life, sensitively tuned to the local culture (9) . The questions for investigation, and the conduct of the study, should be deeply rooted in the ambient culture. He further argues that while many aspects of biology may be universal, the solutions to clinical problems are culture-and location-specific, influenced by social patterns and availability of resources. Nonetheless, collaborative research offers potential benefit to all partners.
Until about 100 years ago, our ability to influence the na tural history of disease was limited. We lacked the tools of description that subsequently have enabled us to categorize diseases into like groups, leading the way to modern epidemiology. For the most part, our lack of understanding of etiology made prevention the application of myth. Our ability to intervene in established disease was likewise constrained by lack of an organized understanding of human physiology and biochemistry. Our crude interventions derived from our rudimentary knowledge. We knew our limits. We applied extreme measures to extreme situations; we tinkered with lesser ills; we comforted and consoled.
The Scientific Method provided the analytic mechanism for major advances in medicine. A strict method of observation and experimentation was provided. The model is ultimately reductionist, dissecting an overall process into experimentally independent components. Further, an orientation was provided, emphasizing the literally observable, the quantifiable, and the repeatable.
In turn, the Scientific Method made possible the Industrial Revolution, which provided the drugs and the supporting technology for a much more powerful and interventivemedicine. Beginning with the control of sepsis, anesthesia, and antibiotics, we gained the ability to alter the natural course of illness. The initial interventions were relatively inexpensive and not very painful. Securing a clean water supply cutbothinfantandadultmortalitywithnomorbidity. Immunizationeradicated diseasewitha needle prick and a few constitutional symptoms.
Antibiotics were slightly different. The literature of syphilology and venerology brings to the oncologist a sense of deja VII as the hair loss, fevers, and rashes of the arsenicals are described. Even the magic of penicillin is tempered by reports of rashes, nausea, vomiting, and anaphylaxis. High-dose penicillin for infective endocarditis brings to mind the necessity and morbidity of venous access. In acute illness the benefits seem obvious, and with the exception of the relatively ineffective arsenicals, neither costs nor risks are major issues.
The next level of intervention was treatment of hypertension. Scientists observed a correlation between a physiologic abnormality (high blood pressure) and a subsequent adverse effect (stroke, myocardial infarction, death). Relatively powerful drugs with long-term but subtle consequences were advocated. However, compliance was low, because the benefit was at a distance from the side effect, and the physiologically oriented physician was not cognizant of the breadth of these subtle adverse effects.
With cancer therapy came a broader basis of medical intervention. Biochemical pathways were identified and exploited, derivativesofa reductionist ScientificMethod that focused on the cancer cell and operated ina conceptual milieu of" extreme situations require extreme measures." Considerable progress has been made, but we now recognize the chronicity ofcancerand the relative inadequacy of our therapy. Many cancers are not yet curable. The disabling toxicities that often ensue from treatment have broached an old question in modern terms: who is the beneficiary of therapy? Further, as the cost of treatment goes up, both government and the public it represents sense a competition for scarce resources. What used to be a private matterbetween physician and patient is now a relationship overseen by the state. What all parties want is a common understanding of what the outcome ofmedicalinterventionis,in its broadest sense.
Illness has a different meaning for each of the observers of the process. For the clinician-scientist it represents aberrant physiology to be recognized and corrected. For the nurse caregiver it means suffering to be relieved. For the family, illness destabilizes relationships and role models. For the patient it ultimately represents a threat to both longevity and expectation.
Each observer has a particular culture and profession-dependent model thatis applied to the process. Each model, in turn, defines a set of parameters against which the severity of the illness and the effectiveness of therapy can be gauged. The physician uses physiologic measures: survival, tumor size, blood pressure. The nurse records symptoms and activity levels. Dr. Deborah Dudgeon's contribution, as a nurse-physician-oncologist deeply involved in palliative care, offers provocative insights into the cultural differences between the healing professions (10) .
"Quality oflife" is a conceptual model intended to represent the perspective of the patient in quantifiable terms. What has evolved over the past decade is a patient-centred subjective model and an impressive series of tools designed to measure change within the construct called "quality of life." Perhaps the relevance of the model lies in its position in the spectrum of outcome measures applied to the evaluation of illness and treatment. Quality of life can be viewed as a "final common pathway" measure, representing the net effect of the disease and all the medical and psychosocial "therapies" brought to bear from the perspective of the patient. Further, to the extent that the model is understood and valued by all the parties to the process, it provides a common language. That being the case, the properties, strengths, and weaknesses of the model must be clearly understood. The use of the model is constrained by the limitations of its applicability, and data acquired should not be rashly extrapolated. Dr. David Cella and Dr. Monika Bullinger provide rigorous overviews of the conceptual foundations of quality of life research and its technology (11, 12) .
Quality of life information can be collected and analyzed from a number of perspectives. For the individual patient followed over time, it represents as natural history the organized aggregate of profilesof physical and occupational function, psychological state, social interaction, and somatic sensation. We are used to collecting such information about physiologic parameters. Quality of liferepresents a broadening of our horizons and a new measure of success. It also opens an avenue to evaluable intervention along any of these dimensions. Properly applied, this assessment technology allows us to measure with some confidence the effects of a multidisciplinary range of professional interventions.
While the focus of this issue is on palliative care, the quality of life model has broad application. Dr. John Ware and his colleagues have demonstrated that different illnesses lead to different patterns of quality of life (13) . For some medically defined diseases, the psychological and socialconsequences outweigh the physiologic concerns. For example, myocardial infarction patients experience major role compromise despite fewer physiologic sequelae than do patients with arthritis. Understanding this process may lead to a more holistic therapeutic approach. The quality of life methodology permits critical evaluation.
When comparing groups of patients, a number of interpretive possibilities are established. The quality of life model makes possible quantitative comparisons linking duration and quality of survival. The potential for serious debate arises when different treatment approaches yield divergent results, one offering duration, the .other quality. While the technique offers no resolution of the dilemma, it does for the first time provide quantifiable data for discussion.
For those interested in health policy, a broadly understood final common pathway outcomẽ It is easy to say that the goal of effective health policy is to maximize societal quality of life. Balancing the competing legitimacies of prevention, intensive treatment, investigational therapy, and compassionate palliation is necessarily an ongoing struggle. Participants in the discussion must develop an understanding of each player's perspective and a respect for the honesty of their legitimate advocacy. The physician must be the patient's advocate. The policymaker must struggle to balance escalating need against defined resources. Adding to the challenge is a frightening lack of solid data about the current state of affairs and the inability to predict which of our new, expensive initiatives will truly bear fruit. To the extent that the quality oflife model illuminates the debate, all of us in the field will have succeeded.
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